Filing metadata

Accession number
0000947871-23-000438
Form type
Form 4
Filer
Damora Therapeutics, Inc.
CIK
CIK 1800315
Filed
Apr 07, 2023
Reporting period
Apr 05, 2023
Description
Insider transaction

Explore SEC Filings Hub